Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 21, 2021
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
[ Fri, May 21st 2021
] - WOPRAI
Thu, May 20, 2021
[ Thu, May 20th 2021
] - WOPRAI
[ Thu, May 20th 2021
] - WOPRAI
[ Thu, May 20th 2021
] - WOPRAI
Matthew DeYoe Initiated (CC) at Strong Buy and Held Target at $42 on, May 20th, 2021
Matthew DeYoe of B of A Securities, Initiated "The Chemours Company" (CC) at Strong Buy and Held Target at $42 on, May 20th, 2021.
Matthew has made no other calls on CC in the last 4 months.
There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Monday, May 10th, 2021
This is the rating of the analyst that currently disagrees with Matthew
- David Coleman of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $40 on, Thursday, May 6th, 2021
